BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu XL, Liu HQ, Li J, Mao CY, He JT, Zhao X. Role of epigenetic in leukemia: From mechanism to therapy. Chem Biol Interact 2020;317:108963. [PMID: 31978391 DOI: 10.1016/j.cbi.2020.108963] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Al-rawashde FA, Al-wajeeh AS, Vishkaei MN, Saad HKM, Johan MF, Taib WRW, Ismail I, Al-jamal HAN. Thymoquinone Inhibits JAK/STAT and PI3K/Akt/ mTOR Signaling Pathways in MV4-11 and K562 Myeloid Leukemia Cells. Pharmaceuticals 2022;15:1123. [DOI: 10.3390/ph15091123] [Reference Citation Analysis]
2 Niu J, Peng D, Liu L. Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells. Front Oncol 2022;12:896426. [DOI: 10.3389/fonc.2022.896426] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Vitkevičienė A, Skliutė G, Žučenka A, Borutinskaitė V, Navakauskienė R. Potential Prognostic Markers for Relapsed/Refractory vs. Responsive Acute Myeloid Leukemia. Cancers (Basel) 2022;14:2752. [PMID: 35681732 DOI: 10.3390/cancers14112752] [Reference Citation Analysis]
4 Su N, Wang Y, Lu X, Xu W, Wang H, Mo W, Pang H, Tang R, Li S, Yan X, Li Y, Zhang R. Methylation of SPRED1: A New Target in Acute Myeloid Leukemia. Front Oncol 2022;12:854192. [PMID: 35359401 DOI: 10.3389/fonc.2022.854192] [Reference Citation Analysis]
5 Chen S, Zhao Y, Liu S, Zhang J, Assaraf YG, Cui W, Wang L. Epigenetic enzyme mutations as mediators of anti-cancer drug resistance. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100821] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Zhang J, Gao X, Yu L. Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins. Front Oncol 2021;11:741746. [PMID: 34540702 DOI: 10.3389/fonc.2021.741746] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Gębarowska K, Mroczek A, Kowalczyk JR, Lejman M. MicroRNA as a Prognostic and Diagnostic Marker in T-Cell Acute Lymphoblastic Leukemia. Int J Mol Sci 2021;22:5317. [PMID: 34070107 DOI: 10.3390/ijms22105317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bi L, Ma T, Li X, Wei L, Liu Z, Feng B, Dong B, Chen X. New progress in the study of germline susceptibility genes of myeloid neoplasms. Oncol Lett 2021;21:317. [PMID: 33692849 DOI: 10.3892/ol.2021.12578] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hassan NM, Refaat LA, Ismail GN, Abdellateif M, Fadel SA, AbdelAziz RS. Diagnostic, prognostic and predictive values of miR-100 and miR-210 in pediatric acute lymphoblastic Leukemia. Hematology 2020;25:405-13. [PMID: 33191875 DOI: 10.1080/16078454.2020.1843753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li R, Guo C, Li Y, Liang X, Su M. Functional benefit and molecular mechanism of vitamin C against perfluorooctanesulfonate-associated leukemia. Chemosphere 2021;263:128242. [DOI: 10.1016/j.chemosphere.2020.128242] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
11 Moujir LM, Llanos GG, Araujo L, Amesty A, Bazzocchi IL, Jiménez IA. Withanolide-Type Steroids from Withania aristata as Potential Anti-Leukemic Agents. Molecules 2020;25:E5744. [PMID: 33291428 DOI: 10.3390/molecules25235744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]